Advanced Computational Modeling and Machine Learning for Risk Stratification, Treatment Optimization, and Prognostic Forecasting in Appendiceal Neoplasms

Jawad S. Alnajjar, Faisal A. Al-Harbi, Ahmed Khalifah Alsaif, Ghaida S. Alabdulaaly, Omar K. Aljubaili, Manal Alquaimi, Arwa F. Alrasheed, Mohammed N. AlAli, Maha A. Alghamdi, Ahmed Y. Azzam

Background: Appendiceal neoplasms account for less than 1% of gastrointestinal cancers but are increasing in incidence worldwide. Their marked histological variations and differences create multiple challenges for prognosis and management planning, as current staging systems are limited in certain aspects for capturing the entire disease complexity. Methods: We synthesized data from 18 large observational studies, including 67,001 patients diagnosed between 1973 and 2024. Using advanced computational modeling, we combined multiple statistical methods and machine learning techniques to improve risk stratification, survival prediction, treatment optimization, and forecasting. A novel overlap-aware weighting methodology was applied to prevent double-counting across overlapping registries. Results: Our multi-dimensional risk model outperformed TNM staging (C-index 0.758 vs. 0.689), identifying five prognostic groups with five-year overall survival ranging from 88.7% (low-risk neuroendocrine tumors (NETs)) to 27.3% (high-risk signet-ring cell carcinomas (SRCC)). Hierarchical survival analysis demonstrated marked variation across histological variants, with goblet cell adenocarcinoma showing the most favorable outcomes. Causal inference confirmed the survival benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in stage IV disease (five-year overall survival (OS) 87.4%) and highlighted disparities in outcomes by race and institutional volume. Time-series forecasting projected a 25% to 50% increase in incidence by 2030, highlighting the growing risk of global burden. Conclusions: By integrating multi-database evidence with advanced modeling and statistical methodologies, our findings demonstrate valuable insights and implications for individualized prognosis, better management decision-making, and health system planning. Our proposed approach and demonstrated methodologies are warranting better progression and advancements in precision oncology and utilization of computational modeling techniques in big data as well as digital health progression landscape.